Svetlana Katsnelson, MD
Endocrinology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Katsnelson’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A135028 · Current
Licensed to practise in California · since 2015 · expires 2027-03-31 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$677 in 2024
Medicaid paid $677 for 18 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 18 | $677 |
| 2024 | 18 | 1 | 13 | $677 |
Drugs they prescribed that Part D paid
$134,481
Pharmacies billed $134,481 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,120) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
774 generic and 282 brand-name prescriptions · $134,481 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 38 | $28,316 | $745 |
| Forteo | 11 | $14,983 | $1,362 |
| Humalog Kwikpen U-100 | 46 | $9,737 | $212 |
| Humalog | 27 | $5,037 | $187 |
| Testosterone | 53 | $4,493 | $85 |
See all 19 drugs
| Ozempic | 38 | $28,316 | $745 |
| Forteo | 11 | $14,983 | $1,362 |
| Humalog Kwikpen U-100 | 46 | $9,737 | $212 |
| Humalog | 27 | $5,037 | $187 |
| Testosterone | 53 | $4,493 | $85 |
| Insulin Glargine-Yfgn | 46 | $4,446 | $97 |
| Levothyroxine | 148 | $2,816 | $19 |
| Liothyronine | 44 | $2,655 | $60 |
| Humulin N Kwikpen | 27 | $2,652 | $98 |
| Methimazole | 138 | $2,599 | $19 |
| Alendronate | 174 | $1,953 | $11 |
| Hydrocortisone | 33 | $1,620 | $49 |
| Ultra-Fine Nano Pen Needle | 29 | $867 | $30 |
| Humulin R | 11 | $608 | $55 |
| Risedronate | 23 | $538 | $23 |
| Ultra-Fine Mini Pen Needle | 11 | $395 | $36 |
| Glipizide | 17 | $224 | $13 |
| Metformin Hcl Er | 23 | $196 | $9 |
| Metformin | 12 | $172 | $14 |
Year by year
| 2024 | 1,120 | 296 | 0% (0) | 25% | $134,481 |
| 2023 | 1,002 | 274 | None | 17% | $110,791 |
| 2022 | 744 | 218 | 0% (0) | 14% | $66,607 |
| 2021 | 449 | 169 | 0% (0) | 15% | $44,219 |
| 2020 | 428 | 136 | 0% (0) | 15% | $54,548 |
| 2019 | 418 | 136 | 0% (0) | 17% | $61,188 |
| 2018 | 419 | 148 | 0% (0) | 20% | $46,165 |
| 2017 | 286 | 105 | 0% (0) | 25% | $66,959 |
| 2016 | 166 | 79 | 0% (0) | 23% | $13,417 |
| 2015 | 388 | 69 | 0% (0) | 36% | $43,985 |
| 2014 | 351 | 71 | 0% (0) | 38% | $44,920 |
| 2013 | 172 | 57 | None | None | $15,867 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Victoza 2-Pak | 15 | $10,938 | $729 |
| Humalog Kwikpen U-100 | 38 | $8,680 | $228 |
| Testosterone | 59 | $5,950 | $101 |
| Humalog | 11 | $4,070 | $370 |
| Levothyroxine | 168 | $3,461 | $21 |
| Humulin N Kwikpen | 19 | $2,916 | $153 |
| Liothyronine | 37 | $2,625 | $71 |
| Hydrocortisone | 25 | $2,167 | $87 |
| Alendronate | 182 | $2,038 | $11 |
| Methimazole | 121 | $1,913 | $16 |
| Ultra-Fine Short Pen Needle | 13 | $717 | $55 |
| Desmopressin Acetate | 11 | $711 | $65 |
| Ultra-Fine Nano Pen Needle | 25 | $681 | $27 |
| Ultra-Fine Mini Pen Needle | 14 | $532 | $38 |
| Glipizide | 19 | $286 | $15 |
| Risedronate | 17 | $204 | $12 |
| Metformin Hcl Er | 26 | $200 | $8 |
| Atorvastatin | 11 | $115 | $10 |
2022: 10 drugs
| Victoza 2-Pak | 21 | $17,294 | $824 |
| Liothyronine | 33 | $3,618 | $110 |
| Testosterone | 34 | $3,511 | $103 |
| Levothyroxine | 137 | $2,873 | $21 |
| Humalog Kwikpen U-100 | 11 | $2,209 | $201 |
| Methimazole | 109 | $2,035 | $19 |
| Alendronate | 153 | $1,853 | $12 |
| Hydrocortisone | 25 | $1,622 | $65 |
| Ultra-Fine Nano Pen Needle | 14 | $253 | $18 |
| Metformin Hcl Er | 11 | $82 | $7 |
2021: 6 drugs
| Victoza 2-Pak | 11 | $10,983 | $998 |
| Testosterone | 16 | $2,822 | $176 |
| Methimazole | 91 | $1,805 | $20 |
| Levothyroxine | 80 | $1,751 | $22 |
| Liothyronine | 13 | $1,165 | $90 |
| Alendronate | 84 | $866 | $10 |
2020: 8 drugs
| Alendronate | 90 | $4,340 | $48 |
| Levothyroxine | 82 | $2,075 | $25 |
| Cinacalcet | 12 | $1,931 | $161 |
| Liothyronine | 23 | $1,907 | $83 |
| Methimazole | 75 | $1,655 | $22 |
| Cabergoline | 12 | $387 | $32 |
| Ultra-Fine Mini Pen Needle | 13 | $237 | $18 |
| Metformin | 12 | $149 | $12 |
2019: 8 drugs
| Levothyroxine | 86 | $2,289 | $27 |
| Methimazole | 86 | $1,865 | $22 |
| Liothyronine | 20 | $1,329 | $66 |
| Alendronate | 75 | $730 | $10 |
| Hydrocortisone | 11 | $374 | $34 |
| Ultra-Fine Mini Pen Needle | 13 | $206 | $16 |
| Veo Insulin | 13 | $125 | $10 |
| Metformin Hcl Er | 11 | $105 | $10 |
2018: 7 drugs
| Lantus | 13 | $6,412 | $493 |
| Humalog | 13 | $3,309 | $255 |
| Levothyroxine | 89 | $2,478 | $28 |
| Liothyronine | 20 | $2,450 | $123 |
| Methimazole | 73 | $1,666 | $23 |
| Alendronate | 72 | $862 | $12 |
| Veo Insulin | 13 | $127 | $10 |
2017: 3 drugs
| Levothyroxine | 60 | $1,863 | $31 |
| Methimazole | 52 | $1,112 | $21 |
| Alendronate | 48 | $676 | $14 |
2016: 4 drugs
| Levothyroxine | 31 | $1,032 | $33 |
| Methimazole | 27 | $622 | $23 |
| Alendronate | 25 | $373 | $15 |
| Metformin Hcl Er | 13 | $124 | $10 |
2015: 8 drugs
| Lantus Solostar | 21 | $7,919 | $377 |
| Lantus | 12 | $3,885 | $324 |
| Humalog | 14 | $3,610 | $258 |
| Levothyroxine | 129 | $2,514 | $19 |
| Synthroid | 19 | $1,122 | $59 |
| Bd Ultra-Fine Pen Needle | 13 | $893 | $69 |
| Metformin | 31 | $602 | $19 |
| Armour Thyroid | 12 | $212 | $18 |
2014: 10 drugs
| Humalog | 16 | $7,778 | $486 |
| Lantus Solostar | 20 | $6,755 | $338 |
| Victoza 3-Pak | 11 | $5,305 | $482 |
| Lantus | 17 | $5,147 | $303 |
| Levothyroxine | 95 | $1,999 | $21 |
| Bd Ultra-Fine Pen Needle | 11 | $762 | $69 |
| Synthroid | 14 | $753 | $54 |
| Metformin | 31 | $436 | $14 |
| Insulin | 12 | $401 | $33 |
| Glimepiride | 24 | $302 | $13 |
2013: 4 drugs
| Proair Hfa | 15 | $754 | $50 |
| Levothyroxine | 15 | $276 | $18 |
| Metformin | 13 | $219 | $17 |
| Glimepiride | 13 | $123 | $9 |
Professional record
- NPI
- 1972829000
- Licence
- CA A135028California A135028: Current · expires 2027-03-31
- Trained
- New York University School of Medicine, 2010
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 710 Lawrence Expy, Department 248, Santa Clara, CA, 95051
- NPI first listed
- 2010-04-14
- NPI last updated
- 2021-12-16
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.